News + Filings Transactions
|
Powell Fred M
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 164k | $4.42 | $724.7k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 254.2k | $2.73 | $693.9k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 181.6k | $2.92 | $530.2k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 177.5k | $2.70 | $479.1k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 217.7k | $2.66 | $579.1k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 150k | $1.76 | $264k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | | 124.2k | $5.60 | $695.7k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | | 204k | $5.60 | $1.1M | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Common Stock | 587k | $5.60 | $3.3M | | 05/24/2022 |
03/03/2022 | ANTARES PHARMA, INC. | ATRS | Grant | | 27.8k | $0.00 | $0 | | 03/03/2022 |
03/03/2022 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | | 11.5k | $3.80 | $43.7k | | 03/03/2022 |
02/16/2022 | ANTARES PHARMA, INC. | ATRS | Grant | | 24.6k | $0.00 | $0 | | 02/16/2022 |
02/16/2022 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | | 11.5k | $3.66 | $42.1k | | 02/16/2022 |
06/13/2021 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 17.3k | $4.45 | $77.1k | | 06/10/2021 |
06/13/2021 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 11.9k | $4.45 | $52.9k | | 06/10/2021 |
06/10/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Stock Option (right to buy) | 164k | $4.42 | $724.7k | | 06/10/2021 |
06/10/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 86k | $4.42 | $380k | | 06/10/2021 |
06/08/2021 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 12k | $4.39 | $52.9k | | 06/08/2021 |
03/01/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 45.8k | $0.00 | $0 | | 03/01/2021 |
03/01/2021 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 19.9k | $4.50 | $89.5k | | 03/01/2021 |
02/17/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 80.4k | $0.00 | $0 | | 02/17/2021 |
02/17/2021 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 35.8k | $4.73 | $169.5k | | 02/17/2021 |
11/12/2020 | ANTARES PHARMA, INC. | ATRS | Purchase | Common Stock | 16.4k | $2.85 | $46.7k | | 11/12/2020 |
06/13/2020 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 8.6k | $2.78 | $23.8k | | 06/11/2020 |
06/11/2020 | ANTARES PHARMA, INC. | ATRS | Grant | Stock Option (right to buy) | 254.2k | $2.73 | $693.9k | | 06/11/2020 |
06/11/2020 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 131.9k | $2.73 | $360k | | 06/11/2020 |
06/08/2020 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 8.7k | $3.13 | $27.2k | | 06/07/2020 |
06/07/2020 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 9.6k | $3.12 | $30k | | 06/07/2020 |
02/19/2020 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 23.8k | $3.53 | $84k | | 02/19/2020 |
02/19/2020 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 63.2k | $0.00 | $0 | | 02/19/2020 |
06/13/2019 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 90.4k | $2.92 | $264k | | 06/13/2019 |
06/13/2019 | ANTARES PHARMA, INC. | ATRS | Grant | Stock Option (right to buy) | 181.6k | $2.92 | $530.2k | | 06/13/2019 |
06/08/2019 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 8.7k | $2.81 | $24.4k | | 06/07/2019 |
06/07/2019 | ANTARES PHARMA, INC. | ATRS | Payment of Exercise | Common Stock | 9.6k | $2.81 | $27k | | 06/07/2019 |
06/08/2018 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 91.7k | $2.70 | $247.5k | | 06/07/2018 |
|
|